Regulation of nutrient uptake by AMP-activated protein kinase.


Journal

Cellular signalling
ISSN: 1873-3913
Titre abrégé: Cell Signal
Pays: England
ID NLM: 8904683

Informations de publication

Date de publication:
12 2020
Historique:
received: 17 08 2020
revised: 05 10 2020
accepted: 06 10 2020
pubmed: 11 10 2020
medline: 30 11 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

AMP-activated protein kinase (AMPK) is the downstream component of a protein kinase cascade that is a key regulator of energy balance at both the cellular and whole-body level. AMPK acts to stimulate ATP production and reduce ATP consumption when cellular ATP levels fall, thereby normalizing energy balance. Given the central role of AMPK in cellular carbohydrate and lipid metabolism, AMPK activation has been proposed to be a therapeutic target for conditions associated with dysfunctional nutrient metabolism including obesity, type 2 diabetes, hepatic steatosis, cardiovascular diseases and cancer. One way by which increased ATP production can be achieved is by increasing the supply of nutrient substrates. In the 1990s, AMPK activation was demonstrated to stimulate glucose uptake in striated muscle, thereby improving substrate supply for ATP production. Subsequently AMPK activation was postulated to underlie the increase in glucose uptake that occurs during muscle contraction. More recently, however, several lines of evidence have demonstrated that AMPK activation is unlikely to be required for contraction-mediated glucose uptake. Furthermore, despite the importance of AMPK in cellular and whole-body metabolism, far fewer studies have investigated either the role of AMPK in glucose uptake by non-muscle tissues or whether AMPK regulates the uptake of fatty acids. In the present review, we discuss the role of AMPK in nutrient uptake by tissues, focusing on glucose uptake out with muscle and fatty acid uptake.

Identifiants

pubmed: 33038517
pii: S0898-6568(20)30284-9
doi: 10.1016/j.cellsig.2020.109807
pii:
doi:

Substances chimiques

AMP-Activated Protein Kinases EC 2.7.11.31
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109807

Subventions

Organisme : British Heart Foundation
ID : PG/12/1/29276
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/13/82/30483
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Fatmah Alghamdi (F)

Institute of Cardiovascular and Medical Sciences, College of Medical, College of Medical, University of Glasgow, Glasgow, UK; Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Yazeed Alshuweishi (Y)

Institute of Cardiovascular and Medical Sciences, College of Medical, College of Medical, University of Glasgow, Glasgow, UK; Department of Clinical Laboratory Sciences, King Saud University, Riyadh, Saudi Arabia.

Ian P Salt (IP)

Institute of Cardiovascular and Medical Sciences, College of Medical, College of Medical, University of Glasgow, Glasgow, UK. Electronic address: ian.salt@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH